CAR-engineered natural killer cells: advancing next-generation cancer immunotherapy Manal M E Ahmed PDF | Full text | Share
Why are we failing to cure so many cases of invasive lobular breast cancer? László Tabár, Peter B Dean, Li-Sheng Chen, Olga Puchkova, Amy Ming-Fang Yen,Hsiu-Hsi Chen, F Lee Tucker, Robert A Smith,Katalin Ormándi, Orsolya Oláh-Németh, Zoltán Veréb, András Vörös, Renáta Bozó PDF | Full text | Share
Use of low dose naltrexone and hydroxycarbamide for mast cell disorders (ISM, MCAS, HaT) B Myers, P Chudakou PDF | Full text | Share
Cancer risk from heavy metals: mechanisms, evidence and toxicity pathways Richard C Semelka,1 Miguel Ramalho2 PDF | Full text | Share
Thyroid dysfunction after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Spiliotis J,1,2,3,5 Spiliotis AE,3 Diamadis A,4 Apostolopoulos A,5 Noskova I,3,6 PDF | Full text | Share